Cataract Surgery. Cataract in diseases classified elsewhere
Conditions
Interventions
Intervention 1: Intervention group 1: In patients in the first group, Propofol at a concentration of 10 mg/cc is used as an intravenous infusion of 100µg/kg/min to maintain anesthesia. Intervention 2:
Sponsors
Bandare-abbas University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: Candidates for Cataract Surgery No History of Systemic Disease Controlled with a History of Systemic Disease
Exclusion criteria
Exclusion criteria: Obesity With BMI More Than 30 Urgent Surgery Uncontrolled Systemic disease With Complication Renal Failure Hepatic Failure Complex Eye Surgery With Cataract Surgery eg. Glucoma Drug Sensitivity
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Extubation time. Timepoint: End of surgery. Method of measurement: From the End of Surgery to Patient Extubation.;Patient Awakening. Timepoint: From the hold of Anesthetic Drugs to Patient Verbal stimulation Response. Method of measurement: Eye Opening.;Nausea and Vomiting. Timepoint: Recovery Room. Method of measurement: Marshal Criteria.;Post Operative Pain. Timepoint: Recovery Room. Method of measurement: Visual analogue Scale.;Postoperative Blood Pressure. Timepoint: Recovery Room. Method of measurement: Non Invasive blood Pressure.;Sedative Status. Timepoint: Recovery Room. Method of measurement: Ramsay Scale.;Heart Rate. Timepoint: Recovery Room. Method of measurement: Monitoring.;Saturation of Peripheral Oxygenation. Timepoint: Recovery Room. Method of measurement: Monitoring.;Discharge Time From Recovery. Timepoint: Recovery Room. Method of measurement: Marshal Criteria. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHashem Jarineshin
Bandare-abbas University of Medical Sciences
Outcome results
None listed